Riverbridge Partners LLC Sells 49,492 Shares of Phreesia, Inc. (NYSE:PHR)

Riverbridge Partners LLC trimmed its holdings in Phreesia, Inc. (NYSE:PHR - Free Report) by 7.2% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 634,396 shares of the company's stock after selling 49,492 shares during the quarter. Riverbridge Partners LLC owned about 1.08% of Phreesia worth $16,215,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Vanguard Group Inc. raised its holdings in shares of Phreesia by 1.3% in the fourth quarter. Vanguard Group Inc. now owns 4,823,110 shares of the company's stock valued at $121,349,000 after buying an additional 61,048 shares during the last quarter. Greenhouse Funds LLLP raised its holdings in shares of Phreesia by 27.9% in the fourth quarter. Greenhouse Funds LLLP now owns 2,873,892 shares of the company's stock valued at $72,307,000 after buying an additional 626,579 shares during the last quarter. Franklin Resources Inc. raised its holdings in shares of Phreesia by 0.8% in the fourth quarter. Franklin Resources Inc. now owns 1,509,617 shares of the company's stock valued at $37,982,000 after buying an additional 11,986 shares during the last quarter. Deerfield Management Company L.P. Series C raised its holdings in shares of Phreesia by 133.6% in the fourth quarter. Deerfield Management Company L.P. Series C now owns 1,271,832 shares of the company's stock valued at $31,999,000 after buying an additional 727,384 shares during the last quarter. Finally, Millennium Management LLC raised its holdings in shares of Phreesia by 83.2% in the fourth quarter. Millennium Management LLC now owns 653,634 shares of the company's stock valued at $16,445,000 after buying an additional 296,863 shares during the last quarter. 92.10% of the stock is owned by institutional investors.

Phreesia Stock Up 3.0%

Shares of NYSE:PHR traded up $0.78 during trading on Monday, hitting $26.99. 505,844 shares of the company's stock traded hands, compared to its average volume of 446,237. Phreesia, Inc. has a 52 week low of $17.07 and a 52 week high of $30.53. The company has a current ratio of 1.95, a quick ratio of 1.95 and a debt-to-equity ratio of 0.02. The company has a market cap of $1.61 billion, a price-to-earnings ratio of -36.47 and a beta of 0.68. The company has a 50-day moving average price of $25.21 and a 200-day moving average price of $26.01.

Phreesia (NYSE:PHR - Get Free Report) last released its earnings results on Wednesday, May 28th. The company reported ($0.07) EPS for the quarter, beating the consensus estimate of ($0.13) by $0.06. The firm had revenue of $115.94 million for the quarter, compared to analysts' expectations of $115.00 million. Phreesia had a negative return on equity of 16.23% and a negative net margin of 9.83%. The business's quarterly revenue was up 14.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted ($0.05) EPS. As a group, research analysts forecast that Phreesia, Inc. will post -1.1 EPS for the current fiscal year.

Insider Buying and Selling

In other Phreesia news, Director Michael Weintraub sold 2,569 shares of the company's stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $27.86, for a total value of $71,572.34. Following the transaction, the director now directly owns 143,039 shares of the company's stock, valued at $3,985,066.54. This represents a 1.76% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Also, CFO Balaji Gandhi sold 8,045 shares of the company's stock in a transaction on Tuesday, April 8th. The shares were sold at an average price of $23.85, for a total value of $191,873.25. Following the completion of the transaction, the chief financial officer now directly owns 108,411 shares in the company, valued at approximately $2,585,602.35. This represents a 6.91% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 49,630 shares of company stock valued at $1,228,707. 5.50% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

PHR has been the subject of a number of research analyst reports. Truist Financial lifted their price target on Phreesia from $34.00 to $35.00 and gave the company a "buy" rating in a report on Thursday, May 29th. Citigroup reiterated a "buy" rating on shares of Phreesia in a research report on Wednesday, May 28th. KeyCorp lowered their price objective on Phreesia from $30.00 to $28.00 and set an "overweight" rating for the company in a research report on Wednesday, April 16th. Canaccord Genuity Group lowered their price objective on Phreesia from $35.00 to $34.00 and set a "buy" rating for the company in a research report on Thursday, May 29th. Finally, Wall Street Zen upgraded Phreesia from a "hold" rating to a "buy" rating in a research report on Sunday, June 1st. Twelve research analysts have rated the stock with a buy rating, According to data from MarketBeat.com, Phreesia currently has a consensus rating of "Buy" and a consensus price target of $31.64.

Phreesia Profile

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.